Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
37.01
-0.82
(-2.17%)
As of 12:39:14 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 18 | 22 | 20 |
| Avg. Estimate | 496.33M | 550.23M | 2.25B | 2.48B |
| Low Estimate | 433.7M | 494.4M | 2.14B | 2.16B |
| High Estimate | 562.2M | 584.46M | 2.42B | 2.77B |
| Year Ago Sales | 425.23M | 637.18M | 2.17B | 2.25B |
| Sales Growth (year/est) | 16.72% | -13.65% | 3.54% | 10.38% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EX9.F | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.63% | 14.23% |
Upgrades & Downgrades
| Downgrade | Wells Fargo: Overweight to Equal-Weight | 2/24/2025 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 2/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/13/2025 |
| Maintains | Citigroup: Buy to Buy | 2/12/2025 |
| Reiterates | Guggenheim: Buy to Buy | 2/12/2025 |
Related Tickers
50BA.F Bicycle Therapeutics plc
9.65
-4.46%
6XP.SG Xspray Pharma AB (publ)
2.8000
+1.08%
471A.F aTyr Pharma, Inc.
3.1400
-16.04%
GBM.F Inovio Pharmaceuticals, Inc.
1.7500
-6.91%
0M4.F Mersana Therapeutics, Inc.
0.5398
+27.64%
7UM.F Ultimovacs ASA
0.1670
-18.93%
22Z.F Zealand Pharma A/S
76.70
-5.47%
4YL.F Nanoform Finland Oyj
1.1600
+1.75%
5CV.F CureVac N.V.
2.8280
-2.48%
CARA Cara Therapeutics, Inc.
4.5200
-2.38%